vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Paycom (PAYC). Click either name above to swap in a different company.

Paycom is the larger business by last-quarter revenue ($544.3M vs $487.7M, roughly 1.1× CLOVER HEALTH INVESTMENTS, CORP.). Paycom runs the higher net margin — 20.9% vs -10.1%, a 31.0% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 10.2%). Paycom produced more free cash flow last quarter ($122.6M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 4.3%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Paycom Software, Inc., known simply as Paycom, is an online payroll and human resource software provider based in Oklahoma City, Oklahoma with offices throughout the United States. It is attributed with being one of the first fully online payroll providers. Founded in 1998, it reported annual revenue of $2.052 billion for 2025, up from $1.883 billion for 2024.

CLOV vs PAYC — Head-to-Head

Bigger by revenue
PAYC
PAYC
1.1× larger
PAYC
$544.3M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+34.5% gap
CLOV
44.7%
10.2%
PAYC
Higher net margin
PAYC
PAYC
31.0% more per $
PAYC
20.9%
-10.1%
CLOV
More free cash flow
PAYC
PAYC
$191.6M more FCF
PAYC
$122.6M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
4.3%
PAYC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
PAYC
PAYC
Revenue
$487.7M
$544.3M
Net Profit
$-49.3M
$113.8M
Gross Margin
83.9%
Operating Margin
-10.1%
28.9%
Net Margin
-10.1%
20.9%
Revenue YoY
44.7%
10.2%
Net Profit YoY
-123.2%
0.2%
EPS (diluted)
$2.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
PAYC
PAYC
Q4 25
$487.7M
$544.3M
Q3 25
$496.6M
$493.3M
Q2 25
$477.6M
$483.6M
Q1 25
$462.3M
$530.5M
Q4 24
$337.0M
$493.9M
Q3 24
$331.0M
$451.9M
Q2 24
$356.3M
$437.5M
Q1 24
$346.9M
$499.9M
Net Profit
CLOV
CLOV
PAYC
PAYC
Q4 25
$-49.3M
$113.8M
Q3 25
$-24.4M
$110.7M
Q2 25
$-10.6M
$89.5M
Q1 25
$-1.3M
$139.4M
Q4 24
$-22.1M
$113.6M
Q3 24
$-9.2M
$73.3M
Q2 24
$7.4M
$68.0M
Q1 24
$-19.2M
$247.2M
Gross Margin
CLOV
CLOV
PAYC
PAYC
Q4 25
83.9%
Q3 25
82.7%
Q2 25
81.9%
Q1 25
84.1%
Q4 24
83.1%
Q3 24
24.5%
80.5%
Q2 24
30.3%
80.8%
Q1 24
23.6%
84.3%
Operating Margin
CLOV
CLOV
PAYC
PAYC
Q4 25
-10.1%
28.9%
Q3 25
-4.9%
22.8%
Q2 25
-2.2%
23.2%
Q1 25
-0.3%
34.9%
Q4 24
-6.4%
30.1%
Q3 24
-2.7%
23.2%
Q2 24
2.0%
21.7%
Q1 24
-6.5%
57.2%
Net Margin
CLOV
CLOV
PAYC
PAYC
Q4 25
-10.1%
20.9%
Q3 25
-4.9%
22.4%
Q2 25
-2.2%
18.5%
Q1 25
-0.3%
26.3%
Q4 24
-6.6%
23.0%
Q3 24
-2.8%
16.2%
Q2 24
2.1%
15.5%
Q1 24
-5.5%
49.4%
EPS (diluted)
CLOV
CLOV
PAYC
PAYC
Q4 25
$2.06
Q3 25
$1.96
Q2 25
$1.58
Q1 25
$2.48
Q4 24
$2.04
Q3 24
$1.31
Q2 24
$1.20
Q1 24
$4.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
PAYC
PAYC
Cash + ST InvestmentsLiquidity on hand
$78.3M
$370.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$1.7B
Total Assets
$541.0M
$7.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
PAYC
PAYC
Q4 25
$78.3M
$370.0M
Q3 25
$375.0M
Q2 25
$532.2M
Q1 25
$520.8M
Q4 24
$194.5M
$402.0M
Q3 24
$288.0M
$325.8M
Q2 24
$254.8M
$346.5M
Q1 24
$208.3M
$371.3M
Stockholders' Equity
CLOV
CLOV
PAYC
PAYC
Q4 25
$308.7M
$1.7B
Q3 25
$340.9M
$1.7B
Q2 25
$344.2M
$1.8B
Q1 25
$336.1M
$1.7B
Q4 24
$341.1M
$1.6B
Q3 24
$342.2M
$1.5B
Q2 24
$324.9M
$1.4B
Q1 24
$292.5M
$1.4B
Total Assets
CLOV
CLOV
PAYC
PAYC
Q4 25
$541.0M
$7.6B
Q3 25
$559.7M
$4.2B
Q2 25
$575.0M
$4.0B
Q1 25
$583.7M
$4.6B
Q4 24
$580.7M
$5.9B
Q3 24
$653.0M
$3.5B
Q2 24
$674.2M
$4.3B
Q1 24
$671.8M
$4.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
PAYC
PAYC
Operating Cash FlowLast quarter
$-66.9M
$196.1M
Free Cash FlowOCF − Capex
$-69.0M
$122.6M
FCF MarginFCF / Revenue
-14.1%
22.5%
Capex IntensityCapex / Revenue
0.4%
13.5%
Cash ConversionOCF / Net Profit
1.72×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$408.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
PAYC
PAYC
Q4 25
$-66.9M
$196.1M
Q3 25
$12.1M
$177.8M
Q2 25
$5.4M
$122.5M
Q1 25
$-16.3M
$182.5M
Q4 24
$34.8M
$160.4M
Q3 24
$50.0M
$92.8M
Q2 24
$44.8M
$132.1M
Q1 24
$25.9M
$148.6M
Free Cash Flow
CLOV
CLOV
PAYC
PAYC
Q4 25
$-69.0M
$122.6M
Q3 25
$11.4M
$79.8M
Q2 25
$4.8M
$60.8M
Q1 25
$-16.5M
$144.8M
Q4 24
$33.3M
$109.0M
Q3 24
$49.6M
$44.6M
Q2 24
$44.4M
$86.5M
Q1 24
$25.5M
$100.9M
FCF Margin
CLOV
CLOV
PAYC
PAYC
Q4 25
-14.1%
22.5%
Q3 25
2.3%
16.2%
Q2 25
1.0%
12.6%
Q1 25
-3.6%
27.3%
Q4 24
9.9%
22.1%
Q3 24
15.0%
9.9%
Q2 24
12.5%
19.8%
Q1 24
7.3%
20.2%
Capex Intensity
CLOV
CLOV
PAYC
PAYC
Q4 25
0.4%
13.5%
Q3 25
0.1%
19.9%
Q2 25
0.1%
12.8%
Q1 25
0.0%
7.1%
Q4 24
0.5%
10.4%
Q3 24
0.1%
10.7%
Q2 24
0.1%
10.4%
Q1 24
0.1%
9.5%
Cash Conversion
CLOV
CLOV
PAYC
PAYC
Q4 25
1.72×
Q3 25
1.61×
Q2 25
1.37×
Q1 25
1.31×
Q4 24
1.41×
Q3 24
1.27×
Q2 24
6.04×
1.94×
Q1 24
0.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

PAYC
PAYC

Recurring$510.3M94%
Interest On Funds Held For Clients$27.2M5%
Implementation And Other$6.8M1%

Related Comparisons